Myriad Genetics (MYGN) Capital Expenditures Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -6.36% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -3.77% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -12.74% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 10.06% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 24.83% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -8.17% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -9.93% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -9.11% |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | -38.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.75% |
| Dec 31, 2025 | -53.01% |
| Sep 30, 2025 | 30.36% |
| Jun 30, 2025 | -25.24% |
| Mar 31, 2025 | -5.60% |
| Dec 31, 2024 | 1.92% |
| Sep 30, 2024 | 5.27% |
| Jun 30, 2024 | 4.94% |
| Mar 31, 2024 | -1.91% |
| Dec 31, 2023 | 92.78% |
| Sep 30, 2023 | -195.49% |
| Jun 30, 2023 | 52.51% |
| Mar 31, 2023 | 98.60% |
| Dec 31, 2022 | 191.03% |
| Sep 30, 2022 | -124.31% |
| Jun 30, 2022 | 68.52% |
| Mar 31, 2022 | 26.67% |
| Dec 31, 2021 | 6.69% |
| Sep 30, 2021 | 32.15% |
| Jun 30, 2021 | 35.72% |